daily dosing. Figure 1 : Difference from placebo for STRIVERDI RESPIMAT for FEV1AUC0-3hr and trough FEV1after 4 weeks Four randomized, double-blind, placebo-controlled dose-ranging trials were performed in patients with asthma, evaluating doses from 2 to 20 mcg. Results from patients with ...